Nitrofurantoin
Nitrofurantoin comes in 21 pill versions in our database, in 5 strengths, from 13 manufacturers. Check the imprint to tell them apart.
Nitrofurantoin pill images
25 mg 1 pill
25 mg / 75 mg 4 pills
- Macrobid 52427285 Nitrofurantoin 25 mg / 75 mg Yellow, capsule, 20 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- Macrobid 52427285 Nitrofurantoin 25 mg / 75 mg Black & yellow, capsule, 20 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- 101 Nitrofurantoin 25 mg / 75 mg Yellow, capsule, 22 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- E122 Nitrofurantoin 25 mg / 75 mg Black & white, capsule, 21 mm Used for urinary tract infections (UTIs) and escherichia coli infections
50 mg 5 pills
- Watson 5780 Nitrofurantoin 50 mg White & yellow, capsule, 16 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- A220 Nitrofurantoin 50 mg White & yellow, capsule, 16 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 00319511 Nitrofurantoin 50 mg Tablet, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 02231015 Nitrofurantoin 50 mg Teva-Nitrofurantoin, Capsule, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 02495503 Nitrofurantoin 50 mg Jamp Nitrofurantoin, Capsule, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
75 mg / 25 mg 1 pill
100 mg 10 pills
- Watson 5781 Nitrofurantoin 100 mg Yellow, capsule, 18 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- MACRODANTIN 100 mg 52427 288 Nitrofurantoin 100 mg Yellow, capsule, 14 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- A221 Nitrofurantoin 100 mg Yellow, capsule, 18 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- MICRO 100 Nitrofurantoin 100 mg Black & yellow, capsule, 19 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- Z 100 Nitrofurantoin 100 mg Black & yellow, capsule Used for urinary tract infections (UTIs) and escherichia coli infections
- NIT 100 Nitrofurantoin 100 mg Black, capsule Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 00312738 Nitrofurantoin 100 mg Tablet, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 02231016 Nitrofurantoin 100 mg Teva-Nitrofurantoin, Capsule, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 02455676 Nitrofurantoin 100 mg PMS-Nitrofurantoin Bid, Capsule, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
- No picture yet DIN 02495511 Nitrofurantoin 100 mg Jamp Nitrofurantoin, Capsule, sold in Canada Used for urinary tract infections (UTIs) and escherichia coli infections
What is Nitrofurantoin used for?
Nitrofurantoin is used for urinary tract infections (UTIs), escherichia coli infections and klebsiella infections.
- Medicine type
- Antibiotic
Official uses from the US prescribing label
Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus.
Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) and other antibacterial drugs,Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) are predisposed to persistence or reappearance of bacteriuria. (see CLINICAL STUDIES ). Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals), other therapeutic agents with broader tissue distribution should be selected. In considering the use of Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals), lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.
From the FDA-approved label on DailyMed (published Sep 24, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.